Effects of rosiglitazone on altered electrical left ventricular papillary muscle activities of diabetic rat

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 376, Issue 6, 2008, Pages 415-421

  Kavak, Servet ^a   Emre, Mustafa ^a   Tetiker, Tamer ^a   Kavak, Tuyana ^a   Kolcu, Zekeriya ^a   Günay, Ismail ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Action potential duration; Diabetes mellitus; Insulin resistance; K+ channels; Kv. 1.3 channel; Rosiglitazone

Indexed keywords

ROSIGLITAZONE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; HEART DEPOLARIZATION; HEART MUSCLE POTENTIAL; HEART PAPILLARY MUSCLE; HEART REPOLARIZATION; HEART VENTRICLE WALL; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MEMBRANE STEADY POTENTIAL; MICROELECTRODE; NONHUMAN; POTASSIUM CURRENT; RAT; STREPTOZOCIN DIABETES;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ELECTRIC STIMULATION; HEART; HEART VENTRICLES; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; PAPILLARY MUSCLES; POTASSIUM CHANNELS; RATS; RATS, WISTAR; STREPTOZOCIN; THIAZOLIDINEDIONES;

EID: 38349153049     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-007-0234-y     Document Type: Article

References (31)

1. Ahn HS, Kim SE, Jang HJ, Kim MJ, Rhie MJ, Yoon SE, Jo YH, Kim MS, Sung KW, Kim SY, Hahn SJ (2007) Open channel block of Kv1.3 by rosiglitazone and troglitazone: Kv1.3 as the pharmacological target for rosiglitazone Naunyn-Schmiedeberg's Arch Pharmacol 374:305-309
2. Aomine M, Nobe S, Arita M (1990) Increased susceptibility to hypoxia of prolonged action potential duration in ventricular papillary muscles from diabetic rats. Diabetes 39 1485-1489
3. + currents in adult rat ventricular myocytes. J Gen Physiol 97:973-1011
4. Bonnevie-Nielsen, MW, Lernmark A (1981) A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin. Diabetes 30:424-429
5. Choi JS, Hahn SJ, Rhie DJ, Yoon SH, Jo YH, Kim MS (1999) Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3. J Pharmacol Exp Ther 291:1-6
6. Eto K, Ohya Y, Nakamura Y, Abe I, Fujishima M (2001) Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle. Eur J Pharmacol 423:1-7
7. Fang Zy, Prins Jb, Marwick Th (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25:543-567
8. Fein FS, Kornstein IB, Strobeck JE, Capasso JM, Sonnenblick EH (1980) Altered myocardial mechanics in diabetic rats. Circ Res 47:922-933
9. Fein FS, Aronson RS, Nordin C, Miller-Green B, Sonnenblick EH (1983) Altered myocardial response to ouabain in diabetic rats: Mechanics and electrophysiology. J Mol Cell Cardiol 15:769-784
10. Gargiulo P, Jacobellis G, Vaccari V, Andreani D (1998) Diabetic cardiomyopathy: Pathophysiological and clinical aspects. Diabetes Nutr Metab 11:336-346
11. 2+transport, fatty acids profiles and ultrastructure of isolated ventricular myocytes. Pflugers Arch 411:564-572
12. Jarret Rj (1989) Cardiovascular disease and hypertension in diabetes mellitus. Diabet Metab Rev 5:547-558
13. Knock GA, Mishra SK, Aaronson PI (1999) Differential effects of insulin-sensitizers troglitazone and rosiglitazone on ion currents in rat vascular myocytes. Eur J Pharmacol 368:103-109
14. Kotchen TA, Yang HY, Reddy S, Hoffman RG (1996) Effect of pioglitazone on vascular reactivity in vivo and in vitro. Am J Physiol 270:R660-R666
15. 2+handling in ventricular myocytes isolated from diabetic rats. Am J Physiol 270:H1529-H1537
16. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270:12953-12956
17. Maghoub MA, Abd-Elfattah AS (1998) Diabetes mellitus and cardiac function. Mol Cell Biochem 180:59-64
18. Magyar J, Rusznak Z, Szentesi P, Szucs G, Kovacs LJ (1992) Action potentials and potassium currents in rat ventricular muscle during experimental diabetes. J Mol Cell Cardiol 24(8):841-853
19. Magyar J, Cseresnyes Z, Rusznak Z, Sipos I, Szucs G, Kovacs L (1995) Effects of insulin on potassium currents of rat ventricular myocytes in streptozotocin diabetes. Gen Physiol Biophys 14(3):191-201
20. Mitchell MR, Powell T, Terrar DA, Twist VW (1984) The effects of ryanodin, EGTA and low-sodium on action potentials in rat and guinea-pig ventricular myocytes: evidence for two inward currents during the plateau. Br J Pharmacol 81:543-550
21. 2+channel. Cardiovasc Res 24:381-389
22. Ramesh B, Pugalendi KV (2007) Influence of umbelliferone on membrane-bound ATPases in streptozotocin-induced diabetic rats. Pharmacol Rep 59(3):339-348
23. Saltiel AR, Olefsky JM (1996) Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45:1661-1669
24. + currents depends on the integrity of the cytoskeleton. J Physiol 514(Pt 3):735-745
25. + currents in rat ventricular myocytes. Circ Res 74:620-628
26. Shimoni Y, Severson D, Giles W (1995) Thyroid status and diabetes modulate regional differences in potassium currents in rat ventricle. J Physiol 488(3):673-688
27. Song J, Walsh MF, Igwe R, Ram JL, Barazi M, Dominguez LJ, Sowers JR (1997) Troglitazone reduces contraction by inhibition of vascular smooth muscle smooth muscle cell Ca2q currents and not endothelial nitric oxide production. Diabetes 46:659-664
28. Unlugenc H, Emre M, Demir C, Guler T, Kavak S, Isik G (2007) Remifentanil-induced mechanical responses and membrane potential changes in human umbilical arteries. Acta Anaesthesiol Scand 51(2):244-251
29. Valenzuela C, Delpon E, Franqueza L, Gay P, Perez O, Tamargo J, Snyders DJ (1996) Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels. Circulation 94:562-570
30. Wagstaff AJ, Goa KL (2002) Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus. Drugs 62:1805-1837
31. Zhang F, Sowers JR, Ram JL, Standley PR, Peuler JD (1994) Effects of pioglitazone in calcium channels in vascular smooth muscle. Hypertension 24:170-175